MedTrace Logo

The Cxbladder Monitoring Study

NCT02700659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 803

Last updated 2020-03-04

No results posted yet for this study

Summary

The aim of this trial is to determine the performance characteristics of the Cxbladder test for the detection of recurrent urothelial carcinoma (UC) in patients with a recent history of urinary tract UC, who have been treated according to standard practice and are undergoing routine investigative cystoscopy.

The gold standard for determination of clinical truth is cystoscopy, plus any follow up investigations relating to the current visit.

Conditions

Interventions

OTHER

Cxbladder

Cxbladder is a non invasive UC detection test measuring five messenger RNA (mRNA) biomarkers present at elevated levels in patients presenting with urothelial carcinoma.

Sponsors & Collaborators

  • Pacific Edge Limited

    lead INDUSTRY

Principal Investigators

  • Paul J O'Sullivan, PhD · Pacific Edge Limited

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-04
Primary Completion
2016-09-23
Completion
2016-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02700659 on ClinicalTrials.gov